Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |